Molecular Correlation for the Treatment Outcomes in Bloodstream Infections Caused byEscherichia coliandKlebsiella pneumoniaewith Reduced Susceptibility to Ceftazidime

This publication has 30 references indexed in Scilit:

• Fatal Infection Due to Extended‐Spectrum Beta‐Lactamase‐Producing Escherichia coli: Implications for Antibiotic Choice for Spontaneous Bacterial Peritonitis
  Clinical Infectious Diseases, 1999
• Is it important to identify extended-spectrum beta-lactamase-producing isolates?
  European Journal of Clinical Microbiology & Infectious Diseases, 1996
• Treatment failure due to extended spectrum βlactamase
  Journal of Antimicrobial Chemotherapy, 1996
• beta-Lactamases in laboratory and clinical resistance
  Clinical Microbiology Reviews, 1995
• Treatment of a meningitis due to an Enterobacter aerogenes producing a derepressed cephalosporinase and a klebsiella pneumoniae producing an extended-spectrum β-lactamase
  Infection, 1991
• Properties of plasmids responsible for production of extended-spectrum beta-lactamases
  Antimicrobial Agents and Chemotherapy, 1991
• Failure of ceftazidime-amikacin therapy for bacteremia and meningitis due to Klebsiella pneumoniae producing an extended-spectrum beta-lactamase
  Antimicrobial Agents and Chemotherapy, 1990
• Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae
  Antimicrobial Agents and Chemotherapy, 1989
• CDC definitions for nosocomial infections, 1988
  American Journal of Infection Control, 1988
• Novel β-lactamase in a clinical isolate of Klebsiella pneumoniae conferring unusual resistance to β-lactam antibiotics
  Journal of Antimicrobial Chemotherapy, 1987